Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Browse by Current Cardiff authors

Number of items: 37.

Fennell, Dean A., Porter, Catharine, Lester, Jason, Danson, Sarah, Blackhall, Fiona, Nicolson, Marianne, Nixon, Lisette, Gardner, Georgina, White, Ann, Griffiths, Gareth and Casbard, Angela 2022. Olaparib maintenance versus placebo monotherapy in patients with advanced non-small cell lung cancer (PIN): A multicentre, randomised, controlled, phase 2 trial. EClinicalMedicine 52 , 101595. 10.1016/j.eclinm.2022.101595

Howell, Sacha J., Casbard, Angela, Carucci, Margherita, Ingarfield, Kate, Butler, Rachel, Morgan, Sian, Meissner, Magdalena, Bale, Catherine, Bezecny, Pavel, Moon, Sarah, Twelves, Chris, Venkitaraman, Ramachandran, Waters, Simon, De Bruin, Elza C., Schiavon, Gaia, Foxley, Andrew and Jones, Robert H. 2022. Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor in metastatic, oestrogen receptor-positive, HER2-negative breast cancer (FAKTION): overall survival, updated progression-free survival, and expanded biomarker analysis from a randomised, phase 2 trial. The Lancet Oncology 23 (7) , pp. 851-864. 10.1016/s1470-2045(22)00284-4

Fennell, Dean A., Porter, Catharine, Lester, Jason, Danson, Sarah, Taylor, Paul, Sheaff, Michael, Rudd, Robin M., Gaba, Aarti, Busacca, Sara, Nixon, Lisette, Gardner, Georgina, Darlison, Liz, Poile, Charlotte, Richards, Cathy, Jordan, Peter-Wells, Griffiths, Gareth and Casbard, Angela 2022. Active symptom control with or without oral vinorelbine in patients with relapsed malignant pleural mesothelioma (VIM): A randomised, phase 2 trial. eClinicalMedicine 48 , 101432. 10.1016/j.eclinm.2022.101432

Jones, Rob, Crabb, Simon, Chester, John, Elliott, Tony, Huddart, Robert, Birtle, Alison, Evans, Linda, Lester, Jason, Jagdev, Satinder, Casbard, Angela, Huang, Chao, Madden, Tracie-Ann and Griffiths, Gareth 2020. A randomised phase II trial of carboplatin and gemcitabine +/- vandetanib in first line treatment of advanced urothelial cell cancer patients not suitable to receive cisplatin. BJU International 126 (2) , pp. 292-299. 10.1111/bju.15096

Jones, Robert H., Casbard, Angela, Carucci, Margherita, Cox, Catrin, Butler, Rachel, Alchami, Fouad, Madden, Tracie-Ann, Bale, Catherine, Bezecny, Pavel, Joffe, Johnathan, Moon, Sarah, Twelves, Chris, Venkitaraman, Ramachandran, Waters, Simon, Foxley, Andrew and Howell, Sacha J. 2020. Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor in metastatic, oestrogen receptor-positive breast cancer (FAKTION): a multicentre, randomised, controlled, phase 2 trial. Lancet Oncology 21 (3) , pp. 345-347. 10.1016/S1470-2045(19)30817-4

Lester, Jason F, Casbard, Angela C, Al-Taei, Saly, Harrop, Richard, Katona, Lajos, Attanoos, Richard L, Tabi, Zsuzsanna and Griffiths, Gareth O 2018. A single centre phase II trial to assess the immunological activity of TroVax® plus pemetrexed/cisplatin in patients with malignant pleural mesothelioma - the SKOPOS trial. OncoImmunology 7 (12) , e1457597. 10.1080/2162402X.2018.1457597

Gillespie, David, Farewell, Daniel, Barrett-Lee, Peter, Casbard, Angela, Hawthorne, Anthony Barney, Hurt, Christopher, Murray, Nick, Probert, Chris, Stenson, Rachel and Hood, Kerenza 2017. The use of randomisation-based efficacy estimators in non-inferiority trials. Trials 18 (1) , 117. 10.1186/s13063-017-1837-3

Harrop, Emily, Kelly, John, Griffiths, Gareth, Casbard, Angela C. and Nelson, Annmarie 2016. Why do patients decline surgical trials? Findings from a qualitative interview study embedded in the Cancer Research UK BOLERO trial (Bladder cancer: Open versus Lapararoscopic or RObotic cystectomy). Trials 17 , 35. 10.1186/s13063-016-1173-z

Jones, Robert J., Crabb, S. J., Chester, John D., Elliott, T., Huddart, R. A., Birtie, A. J., Evans, L., Lester, Jason Francis, Huang, Chao, Casbard, Angela, Madden, Tracie-Ann and Griffiths, Gareth 2016. TOUCAN: A randomised phase II trial of carboplatin and gemcitabine plus /- vandetanib in first line treatment of advanced urothelial cell cancer in patients who are not suitable to receive cisplatin [Abstract]. American Journal of Clinical Oncology 34 (S25) , 448.

Gillespie, David, Hood, Kerenza, Farewell, Daniel, Hawthorne, Antony, Hurt, Chris Nicholas, Probert, Chris, Stenson, Rachel, Barrett-Lee, Peter, Casbard, Angela C. and Murray, Nick 2015. The use of randomisation-based efficacy estimators in non-inferiority trials [Poster Presentation]. Trials 16 (Suppl) , P129. 10.1186/1745-6215-16-S2-P129

Noble, Simon I., Nelson, Annmarie, Fitzmaurice, David, Bekkers, Marie-Jet, Baillie, Jessica, Sivell, Stephanie, Canham, Joanna, Smith, Joanna D., Casbard, Angela, Cohen, Ander, Cohen, David, Evans, Jessica, Fletcher, Kate, Johnson, Miriam, Maraveyas, Anthony, Prout, Hayley and Hood, Kerenza 2015. A feasibility study to inform the design of a randomised controlled trial to identify the most clinically effective and cost-effective length of Anticoagulation with Low-molecular-weight heparin In the treatment of Cancer-Associated Thrombosis (ALICAT). Health Technology Assessment 19 (83) , pp. 1-94. 10.3310/hta19830

Geldart, Thomas, Chester, John, Casbard, Angela, Crabb, Simon, Elliott, Tony, Protheroe, Andrew, Huddart, Robert A., Mead, Graham, Barber, Jim, Jones, Robert J., Smith, Joanna, Cowles, Robert, Evans, Jessica and Griffiths, Gareth 2015. SUCCINCT: an open-label, single-arm, non-randomised, phase 2 trial of gemcitabine and cisplatin chemotherapy in combination with sunitinib as first-line treatment for patients with advanced urothelial carcinoma. European Urology 67 (4) , pp. 599-602. 10.1016/j.eururo.2014.11.003

Noble, Simon, Smith, Joanna D., Baillie, Jessica, Baglin, T., Griffiths, Gareth O., Casbard, Angela, Cohen, Deborah, Fitzmaurice, D., Hood, Kerenza, Rose, P., Cohen, A., Johnson, Miriam, Maraveyas, A., Bell, John, Toone, H. and Nelson, Annmarie 2014. ALICAT: Anticoagulation length in cancer associated thrombosis - a mixed-methods feasibility study. Thrombosis Research 133 (Supp 2) , S220-S220. 10.1016/S0049-3848(14)50032-1

Barrett-Lee, Peter, Casbard, Angela, Abraham, Jacinta, Hood, Kerenza, Coleman, Robert, Simmonds, Peter, Timmins, Hayley, Wheatley, Duncan, Grieve, Robert, Griffiths, Gareth and Murray, Nick 2014. Oral ibandronic acid versus intravenous zoledronic acid in treatment of bone metastases from breast cancer: a randomised, open label, non-inferiority phase 3 trial. Lancet Oncology 15 (1) , pp. 114-122. 10.1016/S1470-2045(13)70539-4

Smith, Joanna D., Baillie, Jessica, Baglin, Trevor, Griffiths, Gareth O., Casbard, Angela C., Cohen, David, Fitzmaurice, David A., Hood, Kerenza, Rose, Peter, Cohen, Alexander T., Johnson, Miriam, Maraveyas, Anthony, Bell, John, Toone, Harold, Nelson, Annmarie and Noble, Simon Ian Robert 2014. A feasibility study to inform the design of a randomized controlled trial to identify the most clinically and cost effective Anticoagulation Length with low molecular weight heparin In the treatment of Cancer Associated Thrombosis (ALICAT): study protocol for a mixed-methods study. Trials 15 (1) , 122. 10.1186/1745-6215-15-122

Noble, Simon Ian Robert, Baillie, Jessica, Smith, J., Baglin, T., Griffiths, G., Casbard, Angela C., Cohen, D., Fitzmaurice, D., Hood, Kerenza, Rose, P., Cohen, A., Johnson, M., Maraveyas, A., Bell, J., Toone, H. and Nelson, Annmarie 2014. Anticoagulation length in cancer associated thrombosis: a mixed-methods feasibility study. Presented at: International Conference on Thrombosis and Hemostasis Issues in Cancer, Bergamo, Italy, 9-11 May 2014.

Harrop, Emily, Kelly, John, Neal, David, Dasgupta, Prokar, Basnett, Gillian, Huddart, Robert, Barham, Allan, Thompson, Colin, Casbard, Angela, Jundi, Hala, Griffiths, Gareth and Nelson, Annmarie 2013. ‘Once I knew there was a choice, I wanted to exercise that choice': using qualitative methods to understand why patients decline surgical trials. Trials 14 (S1) , P9 (2013). 10.1186/1745-6215-14-s1-p9

Powell, James R., Dojcinov, Stefan, King, Louise, Wosniak, Sue, Gerry, Stephen, Casbard, Angela, Bailey, Hazel, Gallop-Evans, Eve and Maughan, Tim 2013. Prognostic significance of hypoxia inducible factor-1α and vascular endothelial growth factor expression in patients with diffuse large B-cell lymphoma treated with rituximab. Leukemia & Lymphoma 54 (5) , pp. 959-966. 10.3109/10428194.2012.733875

Nixon, Lisette Sheena, Wills, Lauren, Staffurth, John Nicholas, Crosby, Thomas David Lewis, Casbard, Angela C. and Griffiths, G. 2009. Implementation of a QA RT substudy for SCOPE 1; Preliminary results for test cases [Abstract]. Clinical Oncology 21 (3) , p. 255. 10.1016/j.clon.2009.01.001,

Morgan, M. A., Lewis, W. G., Casbard, A., Roberts, S. A., Adams, R., Clark, G. W. B., Havard, T. J. and Crosby, T. D. L. 2009. Stage-for-stage comparison of definitive chemoradiotherapy, surgery alone and neoadjuvant chemotherapy for oesophageal carcinoma. British Journal of Surgery 96 (11) , pp. 1300-1307. 10.1002/bjs.6705

Llewelyn, C. A., Wells, A. W., Amin, M., Casbard, Angela C., Johnson, A. J., Ballard, Sian, Buck, J., Malfroy, M., Murphy, M. F. and Williamson, L. M. 2009. The EASTR study: a new approach to determine the reasons for transfusion in epidemiological studies. Transfusion Medicine 19 (2) , pp. 89-98. 10.1111/j.1365-3148.2009.00911.x

Wells, A. W., Llewelyn, C. A., Casbard, Angela C., Johnson, A. J., Amin, M., Ballard, Sian, Buck, J., Malfroy, M., Murphy, M. F. and Williamson, L. M. 2009. The EASTR Study: indications for transfusion and estimates of transfusion recipient numbers in hospitals supplied by the National Blood Service. Transfusion Medicine 19 (6) , pp. 315-328. 10.1111/j.1365-3148.2009.00933.x

Cooke, D., Hurel, S. J., Casbard, Angela C., Steed, L., Walker, S., Meredith, S., Nunn, A. J., Manca, A., Sculpher, M., Barnard, M., Kerr, D., Weaver, J. U., Ahlquist, J. and Newman, S. P. 2009. Randomized controlled trial to assess the impact of continuous glucose monitoring on HbA1cin insulin-treated diabetes (MITRE Study). Diabetic Medicine 26 (5) , pp. 540-547. 10.1111/j.1464-5491.2009.02723.x

Williamson, Lorna M., Stainsby, Dorothy, Jones, Hilary, Love, Elizabeth, Chapman, Catherine E., Navarrete, Cristina, Lucas, Geoff, Beatty, Cynthia, Casbard, Angela C. and Cohen, Hannah 2007. The impact of universal leukodepletion of the blood supply on hemovigilance reports of posttransfusion purpura and transfusion-associated graft-versus-host disease. Transfusion 47 (8) , pp. 1455-1467. 10.1111/j.1537-2995.2007.01281.x

Ghevaert, Cedric, Campbell, Kate, Stafford, Prachi, Metcalfe, Paul, Casbard, Angela C., Smith, Graham A., Allen, Dave, Ranasinghe, Edmund, Williamson, Lorna M. and Ouwehand, Willem H. 2007. HPA-1a antibody potency and bioactivity do not predict severity of fetomaternal alloimmune thrombocytopenia. Transfusion 47 (7) , pp. 1296-1305. 10.1111/j.1537-2995.2007.01273.x

Stanworth, S. J., Dyer, C., Casbard, Angela C. and Murphy, M. F. 2006. Feasibility and usefulness of self-assessment of bleeding in patients with haematological malignancies, and the association between platelet count and bleeding. Vox Sanguinis 91 (1) , pp. 63-69. 10.1111/j.1423-0410.2006.00785.x

Williamson, M., Stainsby, D., Jones, H., Love, E., Chapman, C., Casbard, Angela and Cohen, H. 2006. Haemovigilance reports of post-transfusion purpura and transfusion-associated graft-versus-host disease before and after implementation of universal leucocyte depletion in the UK. Vox Sanguinis 91 (Supp 3) , p. 15. 10.1111/j.0042-9007.2006.vox_v91_is3_mondaysessions.x

Davies, Amanda, Staves, Julie, Kay, Jonathan, Casbard, Angela C. and Murphy, Michael F. 2006. End-to-end electronic control of the hospital transfusion process to increase the safety of blood transfusion: strengths and weaknesses. Transfusion 46 (3) , pp. 352-364. 10.1111/j.1537-2995.2006.00729.x

Grover, M., Talwalkar, S., Casbard, Angela C., Boralessa, H., Contreras, M., Boralessa, H., Brett, S., Goldhill, D. R. and Soni, N. 2006. Silent myocardial ischaemia and haemoglobin concentration: a randomized controlled trial of transfusion strategy in lower limb arthroplasty. Vox Sanguinis 90 (2) , pp. 105-112. 10.1111/j.1423-0410.2006.00730.x

Buck, Jackie, Casbard, Angela C., Llewelyn, Charlotte, Johnson, Tony, Davies, Sally and Williamson, Lorna 2005. Preoperative transfusion in sickle cell disease: a survey of practice in England. European Journal of Haematology 75 (1) , pp. 14-21. 10.1111/j.1600-0609.2005.00412.x

Segal, H. C., Briggs, C., Kunka, S., Casbard, Angela C., Harrison, P., Machin, S. J. and Murphy, M. F. 2005. Accuracy of platelet counting haematology analysers in severe thrombocytopenia and potential impact on platelet transfusion. British Journal of Haematology 128 (4) , pp. 520-525. 10.1111/j.1365-2141.2004.05352.x

Allain, J.-P., Anokwa, M., Casbard, Angela C., Owusu-Ofori, S. and Dennis-Antwi, J. 2004. Sociology and behaviour of West African blood donors: the impact of religion on human immunodeficiency virus infection. Vox Sanguinis 87 (4) , pp. 233-240. 10.1111/j.1423-0410.2004.00578.x

McPherson, K., Metcalfe, M.A., Herbert, A., Maresh, M., Casbard, Angela C., Hargreaves, J., Bridgman, S. and Clarke, A. 2004. Severe complications of hysterectomy: the VALUE study. BJOG - an International Journal of Obstetrics and Gynaecology 111 (7) , pp. 688-694. 10.1111/j.1471-0528.2004.00174.x

Boralessa, H., Cockburn, H., Casbard, Angela C. and Contreras, M. 2004. Review of transfusion practice in orthopaedic surgery. Current Orthopaedics 18 (2) , pp. 126-134. 10.1016/j.cuor.2003.11.001

Strang, J. I. G., Nunn, A. J., Johnson, D. A., Casbard, Angela C., Gibson, D. G. and Girling, D. J. 2004. Management of tuberculous constrictive pericarditis and tuberculous pericardial effusion in Transkei: results at 10 years follow-up. QJM: An International Journal of Medicine 97 (8) , pp. 525-535. 10.1093/qjmed/hch086

Selden, C., Casbard, Angela, Themis, M. and Hodgson, H. J. 2003. Characterization of long-term survival of syngeneic hepatocytes in rat peritoneum. Cell Transplantation 12 (6) , pp. 569-578.

Maresh, M. J. A., Metcalfe, M. A., McPherson, Klim, Overton, C., Hall, V., Hargreaves, J., Bridgman, S., Dobbins, J. and Casbard, Angela C. 2002. The VALUE national hysterectomy study: description of the patients and their surgery. BJOG: An International Journal of Obstetrics & Gynaecology 109 (3) , pp. 302-312. 10.1016/S1470-0328(02)01282-X

This list was generated on Thu Oct 6 04:24:20 2022 BST.